Variant report
Variant | nsv8314 |
---|---|
Chromosome Location | chr8:20585628-20608690 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs555467200 | chr8:20588237-20588238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs368615640 | chr8:20588242-20588243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs541065360 | chr8:20588263-20588264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs34543588 | chr8:20588268-20588269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs74606888 | chr8:20588270-20588271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs76567797 | chr8:20588306-20588307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs545231457 | chr8:20588327-20588328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182040728 | chr8:20588328-20588329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs368673991 | chr8:20588332-20588333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs375492323 | chr8:20588339-20588340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs79596001 | chr8:20588394-20588395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549881821 | chr8:20588403-20588404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs531422719 | chr8:20588429-20588430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs549530218 | chr8:20588431-20588432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs371226079 | chr8:20588506-20588507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs565935770 | chr8:20588509-20588510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs539733133 | chr8:20588524-20588525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs375885676 | chr8:20588532-20588533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs551255751 | chr8:20588542-20588543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs569810203 | chr8:20588608-20588609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185052913 | chr8:20588670-20588671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs35258515 | chr8:20588685-20588686 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs190625506 | chr8:20588686-20588687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs149604035 | chr8:20588714-20588715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs532321266 | chr8:20588738-20588739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs75153921 | chr8:20588768-20588769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs76013963 | chr8:20588781-20588782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs545706302 | chr8:20588807-20588808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs148362723 | chr8:20588864-20588865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs182864361 | chr8:20588870-20588871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs543285995 | chr8:20588910-20588911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs561766282 | chr8:20588912-20588913 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs529003959 | chr8:20588913-20588914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs17093077 | chr8:20588915-20588916 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs34864282 | chr8:20588951-20588952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs56332110 | chr8:20588953-20588954 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs113689569 | chr8:20588974-20588975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs55848611 | chr8:20588986-20588987 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs552423036 | chr8:20589079-20589080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs75401271 | chr8:20589084-20589085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs17604003 | chr8:20589092-20589093 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs186245558 | chr8:20589093-20589094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs538008856 | chr8:20589106-20589107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs80111222 | chr8:20589130-20589131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs147487827 | chr8:20589153-20589154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs552921021 | chr8:20589176-20589177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs139841453 | chr8:20589215-20589216 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs538693049 | chr8:20589244-20589245 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs145352085 | chr8:20589250-20589251 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs112208763 | chr8:20589267-20589268 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Epilepsy | 22083797 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cancer | 18840272 | CNVD |
Breast cancer | 19602461 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 19258508 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Melanoma | 20688739 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:20588200-20589000 | Enhancers | Fetal Brain Female | brain |
2 | chr8:20589000-20589600 | Weak transcription | Fetal Brain Female | brain |
3 | chr8:20589200-20589600 | Enhancers | Fetal Brain Male | brain |
4 | chr8:20589600-20589800 | Enhancers | Fetal Brain Female | brain |
5 | chr8:20589600-20591600 | Weak transcription | Fetal Brain Male | brain |
6 | chr8:20589800-20592200 | Weak transcription | Fetal Brain Female | brain |
7 | chr8:20591600-20597800 | Enhancers | Fetal Brain Male | brain |
8 | chr8:20592200-20592400 | Enhancers | Fetal Brain Female | brain |
9 | chr8:20592400-20592600 | Bivalent Enhancer | Fetal Heart | heart |
10 | chr8:20592400-20592800 | Weak transcription | Fetal Brain Female | brain |
11 | chr8:20592600-20592800 | Enhancers | Brain Hippocampus Middle | brain |
12 | chr8:20592800-20594600 | Enhancers | Fetal Brain Female | brain |
13 | chr8:20593000-20597600 | Enhancers | Fetal Heart | heart |
14 | chr8:20593400-20594600 | Enhancers | Right Ventricle | heart |
15 | chr8:20594000-20594400 | Enhancers | Right Atrium | heart |
16 | chr8:20594400-20595400 | Enhancers | Brain Germinal Matrix | brain |
17 | chr8:20594600-20595400 | Weak transcription | Fetal Brain Female | brain |
18 | chr8:20595400-20596600 | Enhancers | Fetal Brain Female | brain |